Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For individuals with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy, meaning semaglutide or tirzepatide
Weight loss accelerates during this window, and the phase 2 clinical trial data published in the New England Journal of Medicine confirms this dramatically
Contact your GP or diabetes care team if you experience: Persistent irritability, anger, or mood swings that are uncharacteristic for you Symptoms of depression, including low mood, loss of interest in activities, or feelings of hopelessness Anxiety or panic symptoms Significant changes in sleep patterns Difficulty concentrating or memory problems Seek urgent mental health support if you have thoughts of self-harm or suicide by contacting your GP, NHS 111, or in an emergency, call 999 or go to A&E
Compounded Tirzepatide Through Telehealth Licensed telehealth providers offer compounded tirzepatide at $249$399 per month, with the medical consultation, prescription, and delivery all included in that price
US$ 26.02
US$ 22.16
US$ 24.89
US$ 20.64
US$ 21.83
US$ 20.91
US$ 26.38
